title: Final analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus-immune globulin: comparison of the randomized and open-label trials.
authors.affiliation: Department of Medicine, New England Medical Center, Boston, MA 02111.
authors.forename: D R
authors.initials: DR
authors.lastname: Snydman
authors.forename: B G
authors.initials: BG
authors.lastname: Werner
authors.forename: N L
authors.initials: NL
authors.lastname: Tilney
authors.forename: R L
authors.initials: RL
authors.lastname: Kirkman
authors.forename: E L
authors.initials: EL
authors.lastname: Milford
authors.forename: S I
authors.initials: SI
authors.lastname: Cho
authors.forename: H L
authors.initials: HL
authors.lastname: Bush
authors.forename: A S
authors.initials: AS
authors.lastname: Levey
authors.forename: T B
authors.initials: TB
authors.lastname: Strom
authors.forename: C B
authors.initials: CB
authors.lastname: Carpenter
mesh_terms: D000328:Adult; D000914:Antibodies, Viral / Q000008:administration & dosage / Q000032:analysis / Q000592:standards; D002102:Cadaver; D002648:Child; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D006084:Graft Rejection; D006801:Humans; D007116:Immunization, Passive; D016030:Kidney Transplantation; D014019:Tissue Donors
chemical_list: D000914:Antibodies, Viral